We investigated the effectiveness and safety of mirabegron oral treatment in a group of patients with Parkinson's disease (PD) and overactive bladder (OAB), refractory to antimuscarinics.
Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: A pilot study / Gubbiotti, Marilena; Conte, Antonella; Di Stasi, Savino M; Tambasco, Nicola; Giannantoni, Antonella. - In: THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS. - ISSN 1756-2856. - 12:(2019), pp. 1-9. [10.1177/1756286419843458]
Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: A pilot study
Conte, Antonella;
2019
Abstract
We investigated the effectiveness and safety of mirabegron oral treatment in a group of patients with Parkinson's disease (PD) and overactive bladder (OAB), refractory to antimuscarinics.File allegati a questo prodotto
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gubbiotti_Mirabregon_2019.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
451.35 kB
Formato
Adobe PDF
|
451.35 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
